Analyzing...
Loading company...
Fischer Chemic Ltd. engages in trading of chemicals and machineries. The company is headquartered in Mumbai, Maharashtra. The firm is primarily engaged in the trading of laboratory chemicals and machineries.
Nothing flagged for monitoring
“Operates in Healthcare — Equipment & Devices.”
₹309 Cr revenue.
COGS 46.2%, employees 4.9%.
“expect our growth to be in line”
“sector itself is looking at a growth”
“global diagnostic imaging market is experiencing sustained growth, driven by advances in AI integration, portable imaging technologies, and rising demand of early disease detection.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 8.1%▼ | 8.6% |
| ROCE | 12.7%▲ | 12.6% |
| Net Margin | 9.7%▲ | 8.2% |
| EBITDA Margin | 17.3%▲ | 15.6% |
| Debt To Equity | 0.19x▲ | 0.11x |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 |
|---|---|---|---|
| Revenue | ₹309 Cr +178.8% | ₹111 Cr +427.6% | ₹21 Cr |
| Other Income | ₹12 Cr +725.3% | ₹1 Cr +197.7% | ₹0.50 Cr |
| Total Income | ₹321 Cr +186.0% | ₹112 Cr +422.2% | ₹21 Cr |
| COGS | ₹143 Cr +55.7% | ₹92 Cr +456.6% | ₹16 Cr |
| ₹274 Cr +150.5% | ₹109 Cr +465.2% | ₹19 Cr | |
| Profit Before Tax | ₹47 Cr | ₹2 Cr +5.3% | ₹2 Cr |
| Exceptional Items | ₹0.00 Cr +100.0% | (₹0.49 Cr) | ₹0.00 Cr |
| ₹15 Cr | ₹1 Cr +271.3% | ₹0.27 Cr | |
| Net Profit | ₹31 Cr | ₹1 Cr -34.3% | ₹2 Cr |
| Profit (Owners) | (₹2 Cr) ↓ Decline | ₹1 Cr -19.8% | ₹2 Cr |
| Minority Interest | (₹0.14 Cr) +49.7% | (₹0.27 Cr) | ₹0.00 Cr |
| Other Comprehensive Income | ₹0.06 Cr ↑ Recovery | (₹0.01 Cr) | ₹0.00 Cr |
| EPS | ₹0.66 | ₹0.02 | ₹0.03 |
| Diluted Shares | ₹65 Cr | ₹64 Cr | ₹54 Cr |
| Profit Or Loss Of Associates | (₹0.22 Cr) | ₹0.00 Cr | ₹0.00 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fisc...
Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated July 30, 2026, titled "Press Release on Fischer Medical Ventures Secures CDSCO Import Approval for Spincare ...
The Exchange had sought clarification from Fischer Medical Ventures Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements...
Fischer Medical Ventures Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Fischer Medical Ventures Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Fischer Medical Ventures Limited has informed the Exchange about Copy of Newspaper Publication
Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Press Release on Landmark Collaboration Between WFNS Innovation & Technology Committee ...
Fischer Medical Ventures Limited has informed the Exchange about General Updates
Fischer Medical Ventures Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Fischer Medical Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on March 24, 2026.
Fischer Medical Ventures Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Fischer Medical Ventures Limited has informed the Exchange about Copy of Newspaper Publication
Fischer Medical Ventures Limited has informed the Exchange about General Updates
Monitoring Agency Report for Q3
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.